Cite
The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells.
MLA
Guerriero, Claudia, et al. “The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells.” Cells (2073-4409), vol. 10, no. 8, Aug. 2021, p. 1877. EBSCOhost, https://doi.org/10.3390/cells10081877.
APA
Guerriero, C., Matera, C., Del Bufalo, D., De Amici, M., Conti, L., Dallanoce, C., & Tata, A. M. (2021). The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells. Cells (2073-4409), 10(8), 1877. https://doi.org/10.3390/cells10081877
Chicago
Guerriero, Claudia, Carlo Matera, Donatella Del Bufalo, Marco De Amici, Luciano Conti, Clelia Dallanoce, and Ada Maria Tata. 2021. “The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells.” Cells (2073-4409) 10 (8): 1877. doi:10.3390/cells10081877.